Brenda S. Furlow is SVP - GENERAL COUNSEL of BIO-TECHNE Corp. Currently has a direct ownership of 26,092 shares of TECH, which is worth approximately $1.95 Million. The most recent transaction as insider was on Dec 08, 2022, when has been sold 7,450 shares (Common Stock) at a price of $82.12 per share, resulting in proceeds of $611,794. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.1K
0% 3M change
0% 12M change
Total Value Held $1.95 Million

Brenda S. Furlow Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 08 2022
SELL
Open market or private sale
$611,794 $82.12 p/Share
7,450 Reduced 22.21%
26,092 Common Stock
Dec 08 2022
BUY
Exercise of conversion of derivative security
$232,887 $31.26 p/Share
7,450 Added 18.17%
33,542 Common Stock
Dec 07 2022
SELL
Open market or private sale
$65,608 $82.01 p/Share
800 Reduced 2.97%
26,092 Common Stock
Dec 07 2022
BUY
Exercise of conversion of derivative security
$25,008 $31.26 p/Share
800 Added 2.89%
26,892 Common Stock
Aug 08 2022
BUY
Exercise of conversion of derivative security
$99,831 $177.32 p/Share
563 Added 7.95%
6,523 Common Stock
Aug 07 2022
SELL
Payment of exercise price or tax liability
$371,098 $382.97 p/Share
969 Reduced 13.98%
5,960 Common Stock
Aug 07 2022
BUY
Exercise of conversion of derivative security
-
1,969 Added 22.13%
6,929 Common Stock
Oct 26 2021
SELL
Bona fide gift
-
2,660 Reduced 34.91%
4,960 Common Stock
Sep 02 2021
SELL
Open market or private sale
$3,505,928 $510.25 p/Share
6,871 Reduced 47.42%
7,620 Common Stock
Sep 02 2021
BUY
Exercise of conversion of derivative security
$859,219 $125.05 p/Share
6,871 Added 32.16%
14,491 Common Stock
Aug 31 2021
SELL
Open market or private sale
$2,524,350 $504.87 p/Share
5,000 Reduced 39.62%
7,620 Common Stock
Aug 31 2021
BUY
Exercise of conversion of derivative security
$625,250 $125.05 p/Share
5,000 Added 28.38%
12,620 Common Stock
Aug 19 2021
SELL
Open market or private sale
$1,677,295 $474.08 p/Share
3,538 Reduced 31.71%
7,620 Common Stock
Aug 19 2021
BUY
Exercise of conversion of derivative security
$502,311 $115.82 p/Share
4,337 Added 27.99%
11,158 Common Stock
Aug 08 2021
SELL
Payment of exercise price or tax liability
$326,192 $481.82 p/Share
677 Reduced 9.03%
6,821 Common Stock
Aug 08 2021
BUY
Exercise of conversion of derivative security
-
1,374 Added 15.49%
7,498 Common Stock
Feb 12 2021
SELL
Open market or private sale
$3,987,600 $398.76 p/Share
10,000 Reduced 62.02%
6,124 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
$1,065,900 $106.59 p/Share
10,000 Added 38.28%
16,124 Common Stock
Nov 30 2020
SELL
Open market or private sale
$3,279,900 $302.1 p/Share
10,857 Reduced 63.94%
6,124 Common Stock
Nov 30 2020
BUY
Exercise of conversion of derivative security
$1,257,229 $106.59 p/Share
11,795 Added 40.99%
16,981 Common Stock
BSF

Brenda S. Furlow

SVP - GENERAL COUNSEL
Minneapolis, MN

Track Institutional and Insider Activities on TECH

Follow BIO-TECHNE Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TECH shares.

Notify only if

Insider Trading

Get notified when an Bio Techne Corp insider buys or sells TECH shares.

Notify only if

News

Receive news related to BIO-TECHNE Corp

Track Activities on TECH